Self-Assessment: NM Complications of Cancer Care | Cardiac & Pulmonary Manifestations of NMDs-NM Complications of Cancer Care Session Recording

Video Transcription

Video Summary

Summary: The video discusses the neuromuscular immune-related adverse events of immune checkpoint inhibitor therapy used in cancer treatment. It emphasizes the need to understand the pathophysiology of these side effects, precise clinical phenotyping for treatment and communication, and the development of targeted treatment and prevention strategies. It highlights the different immune checkpoints targeted by immune checkpoint inhibitors, the incidence and severity of adverse events in various organ systems, and the lack of reliable animal models for studying these side effects. The video also presents different cases illustrating the challenges in diagnosing and treating neuromuscular complications associated with immune checkpoint inhibitors and chemotherapy. It emphasizes the importance of a multidisciplinary approach and differentiation between various etiologies. The video concludes by summarizing the importance of understanding treatment impacts, utilizing history and physical examination in differentiation, and addressing the complexities of neuromuscular immune-related adverse events associated with immune checkpoint inhibitors.<br /><br />Credits: The video content is not attributed to any specific speaker or organization.

Keywords

neuromuscular adverse events

immune checkpoint inhibitors

cancer treatment

pathophysiology

clinical phenotyping

targeted treatment

prevention strategies

adverse events

organ systems

animal models

chemotherapy

multidisciplinary approach

etiologies